Pharnext

Healthcare 📍 Paris, France 👥 11-50 employees 💰 $19.9M raised 📅 Founded 2007

Pharnext SAS, a biopharmaceutical company, engages in the development of treatments for severe neurological diseases. The company specializes in drug repositioning. Its target pathologies include Charcot-Marie-Tooth disease; and diabetic and toxic peripheral neuropathies, as well as severe neurodegenerative diseases in

🌐 Website in LinkedIn ← All Companies

📊 Company Overview

Sector

Healthcare

Country

France

Employees

11-50

Total Raised · Venture

$19.9M

Founded

2007

Cloud

Unknown

Email

Google Workspace

☁️ Cloud Infrastructure

🔒 Subscribers only Cloud Provider

Workspace	Google Workspace
CDN	🔒 Subscribers only

Detected via DNS records and HTTP response headers as of 2026-06-13.

💰 Estimated Cloud Spend

$108K – $270K / year across cloud providers

🛠 Tech Stack & Marketing

Ad Platforms	🔒 Subscribers only
Analytics & CRM	🔒 Subscribers only
CMS / Platform	🔒 Subscribers only
Frontend Stack	🔒 Subscribers only

Detected from Pharnext's public homepage as of 2026-06-13.

🔍 Compare with Similar Companies

Same sector (Healthcare), similar size

1-10 ☁️ Unknown

Central Printing Group

1-10 ☁️ Unknown

Ortho Clinical Diagnostics Holdings Plc

1-10 ☁️ Azure

Data detected 2026-06-13 · Methodology · Suggest a correction